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We have identified residues on a T ce]l receptor (TCR) ot chain that are important for interaction 
with antigen/major histocompatibility complex (MHC). Using site-directed mutagenesis,  we 
modified DNA encoding the postulated antigen/MHC binding loops on the TCR r  chain expressed 
by the T cell done D5, which recognizes p-azobenzenearsonate--conjugated  antigens presented 
by ceUs bearing I-A  a. These variant TCR a  chains were expressed in conjunction with the wild- 
type D5 TCR 13 chain on the surface of hybridoma cells, and were tested for the ability to recognize 
hapten-conjugated antigens presented by I-A  a. Individual amino acid substitutions in each of 
the three antigen binding loops (or1, cx2, c~3) of the D5 TCR ot chain affected antigen recognition, 
demonstrating that all three loops are important in recognition of antigen/MHC. A subset of 
the single amino acid substitutions completely eliminated antigen recognition, thus identify- 
ing the residues that are particularly important in the recognition of antigenic peptide/MHC 
by the D5 TCR. Because  the wild-type D5 TCR recognizes arsonate and certain structural analogues 
of arsonate conjugated to a variety of protein antigens, we were able to test whether the TCR 
substitutions affected the specificity of the D5 TCR for hapten or carrier antigen. One substitution 
introduced into antigen binding loop or3 markedly altered the pattern of carrier recognition. 
Together, these results verify the Ig model for the TCR and are consistent with the proposition 
that residues forming the first and second antigen binding loops of the TCR contact the MHC, 
while those forming the third loop contact mainly antigenic peptides. 
ecognition of foreign antigenic peptides physically as- 
sociated with proteins encoded in the MHC is accom- 
plished by the c~/13 (or 3r/g) polypeptide chains of the TCR 
(reviewed in reference 1). Sequence similarity of the amino 
acids in V and C domains of the TCR and Ig chains, espe- 
dally in certain residues known to be critical in maintaining 
Ig structure, suggests that the secondary and tertiary struc- 
ture of the TCR resembles that of Ig Fab fragments (2-4). 
By analogy to the antigen binding site on Ig, three regions 
of each TCR chain, formed by loops between 13 sheets, are 
thought to contact the antigenic peptide/MHC protein (5-7). 
Residues in antigen binding loops or1 and or2 on the c~ chain 
and/31 and/32 on the/3 chain are encoded by the variable 
gene segments, while residues in antigen binding loops r 
on the ot chain and 133 on the 13 chain are encoded by the 
V-(D)-J junction. 
Based on the proposed  spatial similarities between TCR 
and Ig antigen binding loops, and their projection onto the 
known three-dimensional  structure of a human MHC pro- 
tein, it has been postulated that TCR. residues in the first 
and second antigen binding loops contact mainly residues 
of the MHC protein, while TCR. residues in the third an- 
tigen binding loop contact antigenic peptides  (5-7).  This 
model is consistent with frequently observed correlations be- 
tween the usage of particular TCR variable gene segments 
(or residues therein) and antigen/MHC reactivities (reviewed 
in reference 1). However, the relative importance of each of 
the six postulated antigen binding loops in recognition of 
antigenic peptides/MHC by a single TCR remains undear. 
Consequently, it is not known whether all six antigen binding 
loops simultaneously  contact the antigenic peptide/MHC. 
Moreover,  it is not known how residues on each antigen 
binding loop contribute to TCR contact with the antigenic 
peptide/MHC. These issues must be resolved in order to un- 
derstand  the molecular basis of TCR recognition. 
We have developed a gene transfer system to test the rela- 
tive importance of particular residues of the TCR in recog- 
nition of antigen/MHC (8). In this report we provide an 
extensive survey of residues of a TCR cz chain using site- 
directed mutagenesis. We show that amino acid substitutions 
at more than one position in all three of the proposed an- 
tigen binding loops of a TCR a  chain markedly affect an- 
tigen recognition. Moreover, an amino acid substitution in 
antigen binding loop cr  altered TCR specificity for peptide 
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TCK based upon the known structure of Ig, demonstrating 
that all three antigen binding loops on the TCP, r  chain 
are required for recognition of antigenic peptides/MHC. 
Materiah and Methods 
Cells.  The arsonate-reactive, I-Aa-restricted T  cell done D5 
(At-5), which utilizes Vcx3.1/JcxTA20'  and V82/D~2-2/Jj~2-5 gene 
segments, has been described previously (9, 10). Its TCIL-negative 
variant GLSlla-, which contains a deletion of the Vex gene seg- 
ment expressed in D5 cells yet continues to express a functional 
TCR. ~ chain, has been characterized previously (8, 11). GLSllcx- 
was fused with the receptor-negative subline of BW5147, BW- 
1100.129.237 (12), to generate the hybridoma GLSllhcx- (8). Sub- 
clone 11h.3r  of the GLSllhot- cell line was used for transfec- 
tion with plasmids described below. Transfectants expressing the 
double amino acid substitution DScx(Y26S,G28V)  are DScxM1 cells 
described previously (8). Culture supernatant from the hamster hy- 
bridoma 145-2Cll (2Cll) was used as a source of antibody to the 
murine CD3-e chain (13). Culture supernatant from the rat hy- 
bridoma B20.6 (14) was used as a source of antibody to murine 
Vt52 and was a gift from B. Malissen (INSERM-CNRS, France). 
TA3 (Ia  ~) (15) cells were used to present  antigens via class II 
MHC molecules and to crosslink anti-CD3 mAb via Fc receptors. 
All  cells were  cultured  in  medium  containing  supplemented 
DME (9). 
DNA Constructions.  The plasmid pFneoD5cxWT has been de- 
scribed previously (8) and contains DNA encoding the wild-type 
D5 TCR. ~  chain. The DNA used to express the wild-type D5 
TCP, r  chain in the present study (mDpFneoDScxWT) was con- 
structed by ligating  the 0.6-kb NheI/SaclI fragment containing 
the m13 origin of  replication from the vector CDM8 into the EcogI 
site of pFneoDSc~WT. The orientation of this fragment was such 
that superinfection of dut-ung-  CJ236 bacteria carrying  mDp- 
FneoD5cxWT as a plasmid with helper phage MDK07 generated 
uracil-labded, single-stranded DNA encoding the D5 TCK in the 
sense orientation. Antisense mutagenic ollgonudeotides, 20 nucleo- 
tides in length, were synthesized and contained one to three nucleo- 
tide differences positioned equidistant from the ends of the oligo- 
nudeotide. Mutagenic plasmids were generated by the method of 
Kunkel (16) using reagents supplied in the Muta-Gene Kit (Bio- 
Pad Laboratories, Richmond, CA). Mutant plasmids were selected 
by transformation into dut+ung + bacteria, MC1061 or XL-1 Blue, 
and were screened by sequencing with dideoxynucleotides using 
Sequenase (U.S. Biochemical  Corp., Cleveland, OH). The integrity 
of plasmids containing TCtL ~  DNA variants was confirmed by 
sequencing near the region of  interest and by restriction mapping. 
Sequencing an average of 180 bp of the VJ regions, representing 
>50% of the entire variable regions, of eight of the variant D5 
TCR that decreased antigen responses >10-fold and three that had 
no effect on antigen responses did not reveal any mutations other 
than those deliberately introduced.  Variant D5 TCK DNA, and 
cells derived from these DNA transfected into 11hcx- calls, are 
designated by the amino acid substitutions they carry. For example, 
DSo~(Y26S) represents the substitution  of Ser for Tyr at position 
26 of the D5 TCR c~ chain (numbering  according to Chothia et 
al. [5] using the single-letter amino acid code as shown in Fig. 1). 
Transfection of 11h.3~-  Cells.  11h.3r  cells were translated by 
dectroporation as before with a Cell Porater (Bethesda Research 
Laboratories, Gaithersburg, MD) (8). In some experiments a Gene 
Pulser apparatus (Bio-Pad Laboratories) was used; in these cases, 
6  x  10  ~ 11h.3r  cells were suspended in 0.75 ml of serum-free 
DME with 25 ttg plasmid DNA (diluted in 10 ~tl 10 mM Tris, 
pH 8, 1 mM EDTA), subjected to 250 V, 960 ~tF, and left at room 
temperature for an additional 10 min. Cells were cultured in DME 
containing 10% FCS for 2 d to allow recovery from dectropora- 
tion. Cells expressing  surface  2X2K  were selected  by growth in DME 
containing 5% FCS and I mg/ml G-418 sulfate (Gibco Laborato- 
ties, Grand Island, NY) for 2 wk, and were isolated after sequen- 
tial incubation with 2Cll anti-CD3  mAh and goat anti-mouse 
antibody coupled to magnetic beads (Dynabeads; Dynal,  Great 
Neck, NY) as suggested by the manufacturer. Single cell clones 
were obtained by limiting dilution and were tested for surface CD3 
expression. Clones  that were >95%  CD3 + were tested for re- 
sponses to 2Cll anti-CD3 mAb and Ars-Ova, as described below. 
Representative clones were chosen for further analysis of antigen 
responses and were maintained in medium containing G418. Sur- 
face expression of CD3 was routinely tested in transfectants within 
2 wk of antigen assays to ensure that clones remained CD3 +. Sur- 
face expression  of  CD4, CD45, and LFA-1 in transfectants  exhibiting 
decreased  antigen responses was comparable with that in DSolWT 
cells, as determined by flow cytometry, indicating that the decreases 
in antigen recognition observed were not due to the loss of these 
accessory molecules (data not shown). 
Flow Cytometry.  2  x  10  s cells were resuspended in 50 #l of 
50% FCS in wash solution (2% FCS, 0.1% sodium azide, in PBS) 
and mixed with 50/~l of primary antibody diluted in wash solu- 
tion. Final antibody concentrations were 10% 2Cll (or 50% B20.6 
rat anti-murine V/~2) culture supernatant and 0.05% normal ham- 
ster serum as control solution. Cells were incubated on ice for 30 
rain,  washed, and incubated on ice for 30 rain in 100 #l of sec- 
ondary antibody  containing  5%  normal  goat  serum  and  PE- 
conjugated goat anti-mouse antiserum that crossreacts with ham- 
ster antibodies (Tago Inc., Burlingame, CA) diluted 1:100 in wash 
solution.  Cells were washed and analyzed via a FACScan  |  flow 
cytometer using the FACScan  |  program (Becton Dickinson & Co., 
Mountain  View, CA). 
Imrnunoprecipitation and Electrophoresis of lodinated Cell Su~ace Pro- 
teins.  Surface  proteins of cells expressing transfected TCtL chains 
were iodinated, sohbilized with 1% digitonin,  and immunopre- 
cipitated with 2Cll anti-CD3 mAb as described (10). The immu- 
noprecipitate was subjected to sequential dectrophoresis in a non- 
equilibrium pH gradient gel (NEPHGE) and 12,5% SDS-PAGE 
as described (17). 
Preparation of Antigens.  Intact  chicken  OVA, turkey  OVA 
(tOVA), bovine gamma globulin (BGG), hen egg lysozyme (HEL), 
rabbit gamma globulin (KGG), and KLH were conjugated with 
diazotizedp-azobenzenearsonate (Ars-),p-benzoate (C-), orp-azo- 
benzenesulfonate (S-) as described previously (9). 
11,2 Secretion Assay.  10  s hybridoma cells were cultured with 
10  S TA3 APC in the presence of several dilutions of antigen or 
stimulatory  anti-CD3  mAb in triplicate wells of 96-well micro- 
titer plates for a final volume of 200 ~tl. Since free antigen concen- 
trations  >300  ~tg/rrd were toxic  to CTLL-20 cells, APC were 
prepulsed with antigen when 2,000-3,000 ~tg/ml antigen was tested. 
After 20 h, supernatants were harvested and frozen before the assay 
on CTLL-20 cells. Proliferation of CTLL-20 cells in response to 
culture supernatants was carried out as described previously (18). 
Alternativdy, viability of CTLI,20 ceils was determined 24-48 h 
later by measuring reduction of MTT (3-[4,5-dimethylthiazol-2- 
yl]-2,5-diphenyltetrazolium  bromide;  Sigma Chemical  Co.,  St. 
Louis, MO) by the cells on a Vmax microplate reader (Molecular 
Devices Corp., Menlo Park, CA) using a reference wavelength of 
650 nm and a test wavelength of 570 nm, as described by Tada 
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of sample means. As representative examples, standard deviations 
are indicated in Fig. 4 B when greater than one-half of the symbol 
height.  Comparisons  were made between a single concentration 
of supematants generated from cells bearing variant TCR (usually 
diluted 1:4) and serial twofold dilutions of supematants generated 
from cells bearing  the wild-type D5 TCR (usually diluted  1:4 
through  1:16). Supernatants  in  which  responses  to  anti-CD3 
mAb by cells bearing  wild-type TCR matched  most closely to 
supernatants  from cells bearing variant TCR were chosen to cal- 
culate relative antigen recognition as: (antigenwr/antigen,-~,n,)  x 
(2Cl1~,=/2Cllwr);  where antigen and 2Cll are the concentra- 
tions of antigen or 2Cll anti-CD3  mAb that stimulated identical 
I1,2 secretion in transfectants expressing wild-type or variant TCR. 
In every experiment,  transfectants expressing variant TCR were 
tested along with a representative transfectant expressing wild-type 
D5 TCR. Whenever possible, comparisons in dose-response curves 
were made in the linear portion of the I1.2 response curve. When 
no antigen response was detected, the highest antigen concentra- 
tion tested was used to calculate relative antigen  recognition;  in 
these cases, numbers potentially  overestimate antigen  responses. 
Results 
Outline Structure of the I)5 TCR.  We were interested in 
identifying the regions and, in more detail, particular residues 
of the D5 TCR that  are important  in recognition of anti- 
genic peptide/MHC. We have used the proposed outline struc- 
ture for the TCR based upon the known structure of Ig (5) 
to predict the amino acids of the D5 TCR that contact an- 
tigen/MHC  (Fig.  1). Taking into account the conservation 
of residues predicted to form the interface between Vo~ and 
VB domains (squares) and residues buried between ~ strands 
(triangles) forming paired,  tightly packed B sheets, we have 
identified amino acid residues predicted to form the/3 strands 
A to G (dotted boxes) and the antigen binding loops or1, or2, 
and or3 (solid boxes) of the D5 TCR cr chain. We have tested 
the role of the residues predicted to form the antigen binding 
loops of the D5 TCR ot chain by alanine-scanning  mutagenesis. 
We have chosen to substitute with Ala because its substi- 
tution removes side chains beyond the ~  carbon and should 
not alter the conformation  of the main-chain  polypeptide. 
Systematic Ala substitution has been useful in the study of 
a number of proteins,  including the Ig-like molecule CD4 
(20, and see Discussion).  We did not substitute Pro-30 or 
Pro-54 with Ala because of the special structural constraints 
often dictated by Pro in protein structure: Pro has been shown 
to play an important role in determining the structure of the 
canonical antigen binding  loop L3 in Ig (21,  22).  We did 
not substitute Val-55 or Val-56 because in the Ig structures 
complexed with HEL that have been determined to date, light 
chain residues in the second antigen binding loop do not make 
extensive contacts with antigen (23). In addition to the amino 
acid residues that form the predicted antigen binding loops, 
we have  substituted  Tyr-24 with  Ala;  although  Tyr-24 is 
predicted to be the last residue forming the B ~  strand, we 
thought  that Tyr might be especially important  in antigen 
recognition by the D5 TCR (see Discussion). Moreover, anal- 
ogous to the situation observed with Ig, and as emphasized 
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Figure 1.  Outline  structure of D5 TCR ot chain. The structure of the 
D5 TCR c~ chain variable domain is represented according to Chothia 
et al. (5), highlighting the residues that determine the Vc~ framework 
structure. Arrows indicate the borders of the V, J, and C regions. Dotted 
boxes surround residues  comprising/~ strands A-G (bo/d/etters),  while solid 
boxes surround residues that form the antigen binding loops oil, oe2, and 
o~3 between  ~8 strands. Symbols  above the sequence  indicate residues that 
are used in the alignment; triangles represent residues that are buried be- 
tween the 15 sheets, squares are residues that make contact with the VB 
domain, and circles are residues in turns. Open symbols  above sequences 
signify residues that comply with those residues that determine the Ig 
fold in TCR ot chain; filled symbols  denote those that are represented in 
<40% of the TCR analyzed by Chothia et al. (5). The single-letter code 
for amino acid residues is used. The numbering system used is that of 
Chothia et al. (5), except in the c~3 region, where residues are numbered 
consecutively  93-98; the next consecutive  residue, Phe-105, is the first res- 
idue of the G B strand. 
by Chothia et al.  (5), framework residues might  also con- 
tribute to contact with  antigen/MHC. 
A Model TCR.  We have utilized thep-azobenzenearsonate~ 
specific T cell clone D5 (At-5) and the T cell hybridoma de- 
rived from D5 cells, DSh3, in previous studies involving T 
cell recognition of antigenic peptides/MHC (8-10, 24, 25). 
Recognition of arsonate-conjugated antigens/MHC by the 
antigen receptor expressed on the T cell clone D5 is similar 
to recognition by other TCR: D5 cells recognize haptenated 
peptides derived from intact hapten-conjugated proteins (E. A. 
Nalefski, and A. Rao, manuscript in preparation).  D5 cells 
recognize antigens  in an MHC-restricted  manner;  that  is, 
D5 cells recognize antigens presented by a specific MHC pro- 
tein,  bA  d (9). As is the case with other T  hybridomas, the 
recognition of antigen by D5h3 cells is sensitive to specific 
amino acid substitutions introduced into the NH2-terminal 
end of the predicted c~ helix on the/5 chain of the bA  d mol- 
ecule (E.  A.  Nalefski,  unpublished  results). 
1555  Nalefski  et al. o.4o  75 
0.20 
0.0001  0.001  0.01  0.1  1  10  100  1,000 
E  t- 
O  o.lo 
IZ) 
(D 
6 
o.~ 
c- 
O  ~ 
I]) 
.J 
0.2D 
0.10  . 
...--'~ 
m  ,."" /  .-"" 
m  ,'  :  ..'" 
P  .."* 
Am-HEL 
......  ￿9  .....  /"  / 
~All~ 
----m  -  /  /"  ..A 
0.00  ......  "1  "  ...... I  .......  1  .......  I  .....  "I  ...... 1  .......  "1  .......  I  ...... 
0.0001  0.001  0.01  0.1  1  10  100  1,(XX) 
Antigen Concentration (pg/rnl) 
Figure 2.  Antigen specificity of the D5 TCtL II.-2 secretion by trans- 
fectant expressing the wild-type D5 TCK was measured in response to 
OVA conjugated with arsonate or its structural  analogues (top) or to a 
variety of arsonate-conjugated antigens cultured with I-Ad-bearing TA3 
APC (bottom). Shown at top is the response to OVA conjugated with ar- 
sonate (filled circles), benzoate (filled squares),  or sulfonate (filled triangles). 
Shown at the bottom is the response to arsonate conjugated to OVA (filled 
circles, solid line), KLH  (filled squares, solid line), tOVA (filled triangles,  solid 
line), HEL (filled circles, dashed line), BGG (filled squares, dashed line), and 
KGG  (filled triangles,  dashed line). Results represent average MTT reduc- 
tion measured by OD 570-650 nm in triplicate wells of the IL-2-dependent 
cell line CTLL-20 in response to hybridoma culture supernatants. 
Using the gene transfer system described previously (8), 
we reconstituted the antigen specificity of the D5 TCR by 
transfecting DNA encoding the D5 TCK ot chain into a hy- 
bridoma derived from D5 cells that lacked expression of the 
D5 TCR o~ chain. Cells expressing the transfected wild-type 
D5 TCK ot chain displayed the characteristic hierarchy of rec- 
ognition by the D5 TCK for OVA conjugated with arsonate 
or its analogues (Fig. 2 top) or various carrier antigens con- 
jugated with arsonate (Fig. 2, bottom). This hierarchy  of hapten 
reactivity is also displayed when these haptens are conjugated 
to the OVA peptide spanning amino acid residues 36-50 (8, 
and E. A. Nalefski and A. Rao, manuscript in preparation). 
This hierarchy of antigen reactivity allowed us to ask whether 
amino acid substitutions introduced into the D5 TCK ot chain 
selectively affected its hapten or carrier specificity. 
The Effect of Amino Acid Substitutions Introduced into the D5 
TCR cr Chain on the Recognition of Ars-OVA/I-A a.  Surface 
3O 
15 
E 
t- 
O 
45 
15 
::  11 h,3a  -  .~ 
O5a(i98A) 
10  100 
r:  D5a(T29A) 
1,000  10  100 
Fluorescence Intensity (log) 
1,000 
Figure 3.  Surface  expression of TCR/CD3 in cells expressing the wild- 
type or variant forms of the D5 TCR (x chain. Surface expression of the 
TCK/CD3 complex was measured by flow cytometry  of recipient and 
transfected cells after incubation with 2Cll anti-CD3 mAb (solid lines) 
or normal hamster serum (dotted lines), and fluorescent secondary antibody. 
DS(xWT, D5o~(I98A), and D5o~(T29A) are representative dones derived 
by  transfecting  recipient  11h.30~- cells  with  m13pFneoDSo~WT, 
D5ot(I98A), and D5c~(T29A), respectively. Shown is an analysis of 4,500 
cells. Cells bearing other variant D5 TCR also expressed comparable levels 
of the surface TCR/CD3 complex. Cells exhibiting decreased antigen re- 
sponses also expressed the epitope detected by the mAb B20.6 anti-rou- 
tine Vf32 at levels comparable with that expressed by cells expressing 
D5olWT. 
expression of TCR/CD3 by representative cells expressing 
transfected wild-type or variant D5 TCR ot chains is shown 
in Fig. 3. Although surface expression of TCR/CD3 in most 
transfectants was comparable, we have observed minor differ- 
ences in the levels of surface TCR expression in some clones 
and concomitant variability in the amount of I1.2 secreted 
in response to 2Cll anti-CD3 mAb (data not shown).  To 
control for such discrepancies, we normalized II-2 secretion 
by each of the transfectants, as described in Materials and 
Methods and shown in Fig. 4/1. In Fig. 4 A, left, a 1:4 dilu- 
tion of supernatant from transfectant D5(x(N94A) contained 
as much I1.2 secreted in response to anti-CD3 mAb as did 
a 1:8 dilution of supernatant  from DSotWT cells. In Fig. 
4 A, right, comparison of 1:4 dilution of supernatant  from 
D5ot(N94A)  cells to  a  1:8  dilution of supernatant  from 
D5otWT cells revealed that the antigen dose-response dis- 
played by DSot(N94A) cells had been shifted to at least 5,000- 
fold higher concentrations  of antigen. 
We tested the ability of the transfectants expressing variant 
D5 TCR to recognize Ars-OVA presented by I-Aa-bearing 
TA3 cells. Several  experiments were performed in which dose- 
response curves from each transfectant expressing variant D5 
TCR o~ chains were compared with those from cells expressing 
the wild-type D5 TCR, examples of which are shown in Fig. 
4 B. The amino acid substitution D5ct(R97A) had little effect 
on antigen recognition (top left), even  when relative responses 
to anti-CD3 mAb were taken into account. The amino acid 
substitution D5c~(I98A) caused an '~200-fold decrease in the 
1556  The Antigen Binding Site on the T  Cell Receptor ot Chain "
F
 
:
~
;
 
~
9
~
 
L
S
S
I
 
￿
9
 
;
z
!
s
 
p
q
m
.
g
s
 
;
t
l
~
 
j
o
 
i
F
[
[
 
o
u
o
 
u
~
t
[
;
 
a
o
3
;
~
 
I
 
,
;
q
~
 
s
u
b
o
r
n
 
;
i
d
u
~
s
.
~
o
 
s
Q
S
 
;
~
u
!
 
u
~
;
 
"
i
~
 
"
$
.
~
 
u
!
 
s
~
 
'
p
u
!
u
u
o
~
,
 
s
e
,
,
~
 
u
o
p
~
o
o
s
 
i
~
q
I
"
 
V
 
u
!
 
s
e
 
;
i
q
.
[
s
s
o
d
 
s
~
 
g
p
s
o
p
 
s
~
 
p
o
q
:
)
~
e
m
 
s
~
.
~
 
q
y
m
 
f
G
~
-
,
u
e
 
o
:
~
 
o
s
u
o
d
s
~
.
~
 
u
!
 
u
o
p
o
~
s
 
~
q
I
 
q
:
)
.
~
q
t
~
 
.
~
o
j
 
(
s
~
.
~
 
1
 
p
~
/
r
~
 
'
s
,
;
,
/
:
u
!
:
,
 
P
/
I
~
 
,
1
,
A
~
.
X
)
~
{
I
 
m
o
z
j
 
p
:
~
u
;
,
~
 
s
;
t
[
,
~
a
.
z
o
d
n
s
 
o
;
 
(
~
u
.
~
 
I
 
p
.
l
o
;
 
'
s
;
u
~
n
b
s
 
P
I
I
~
 
;
m
I
.
 
[
P
 
q
~
'
~
 
m
o
z
~
 
s
:
m
~
e
a
.
t
.
-
,
d
n
s
 
~
o
 
u
o
!
:
m
[
~
 
t
,
:
'
[
 
~
 
i
o
 
u
o
s
.
u
~
d
m
o
o
 
e
 
s
!
 
u
t
~
,
o
q
s
 
"
s
l
i
~
 
t
~
Y
3
.
,
 
q
:
L
 
[
~
 
P
.
~
m
I
 
r
~
 
V
A
O
'
S
a
V
.
~
O
 
s
:
m
n
o
a
.
~
 
I
X
~
r
 
~
q
:
~
 
o
~
 
;
s
a
o
d
s
o
.
~
 
u
!
 
p
o
a
n
s
~
m
 
s
~
.
r
 
(
V
i
;
6
g
)
x
~
I
.
Z
O
 
'
(
y
E
/
d
x
)
~
Q
 
'
(
V
8
6
i
)
x
)
~
Q
 
'
(
V
/
.
6
"
,
~
l
)
X
)
~
{
i
 
S
u
.
~
s
s
~
.
a
t
x
~
 
s
:
m
~
:
x
~
s
u
c
a
~
 
~
!
:
~
e
~
s
o
.
~
a
 
p
u
e
 
,
L
A
~
X
)
~
G
 
S
u
!
s
s
o
z
(
L
,
~
 
s
i
[
~
 
g
q
 
u
o
!
:
~
o
.
L
~
s
 
U
I
I
 
(
R
)
 
"
(
s
~
U
?
l
 
P
~
l
r
'
~
)
 
s
i
P
:
)
 
,
I
,
.
,
~
x
)
f
C
I
 
m
o
.
~
 
p
:
~
t
.
~
u
~
8
 
~
u
,
~
u
.
~
n
s
 
~
o
 
(
S
~
l
,
?
U
.
~
 
,
M
o
)
 
u
o
p
n
l
!
p
 
9
I
:
I
 
p
u
l
~
 
'
(
s
~
a
~
b
~
 
,
M
o
)
 
g
:
I
 
'
(
s
~
a
~
!
~
 
u
M
o
)
 
~
:
~
 
~
 
f
f
~
.
u
~
 
p
.
~
d
m
o
:
)
 
(
s
~
U
!
l
 
p
.
.
l
O
S
 
'
s
~
b
r
 
P
"
/
I
~
 
S
i
l
~
 
(
V
I
'
6
N
)
~
~
 
m
o
~
 
p
:
~
a
~
a
~
 
~
u
,
n
e
u
a
~
d
n
s
 
~
t
l
~
 
j
o
 
u
o
.
n
n
i
~
 
}
,
:
!
 
~
 
s
!
 
a
.
~
t
,
 
o
q
s
 
"
S
l
I
~
 
t
;
Y
2
,
 
q
:
L
 
~
s
 
p
a
m
l
~
 
0
~
/
~
.
~
)
 
V
A
O
-
S
a
V
 
.
m
 
0
f
~
)
 
q
y
m
 
~
;
C
I
D
-
!
;
u
t
 
I
I
D
~
 
j
o
 
s
:
l
u
n
o
u
~
 
p
~
m
 
;
)
q
:
l
 
o
:
~
 
o
s
u
o
d
s
~
.
;
 
u
!
 
p
.
m
s
,
m
 
s
e
.
s
,
.
 
(
V
/
~
6
N
)
n
f
G
 
.
~
o
 
J
,
.
~
h
~
o
~
o
 
S
u
!
s
s
;
a
d
x
~
 
S
l
I
~
 
.
~
q
 
u
o
!
:
~
o
.
L
~
s
 
i
~
q
I
 
(
V
)
 
"
u
F
q
~
 
~
 
"
~
I
3
.
[
,
 
S
G
 
o
q
~
 
.
p
 
s
u
u
o
]
 
~
u
~
.
u
~
 
a
o
 
;
d
X
a
-
p
 
.
1
~
.
 
~
u
.
[
s
s
;
a
d
x
;
 
s
i
l
o
:
)
 
o
^
p
~
u
o
s
o
x
d
~
 
.
~
q
 
v
V
-
I
I
Y
A
O
-
~
V
 
a
o
 
q
y
m
 
~
:
C
I
D
-
!
:
~
u
l
~
 
m
 
s
o
s
u
o
d
s
~
I
 
"
t
i
,
 
a
a
~
,
~
!
~
[
 
(
I
t
u
/
~
r
l
)
 
U
O
!
I
R
J
l
U
O
O
U
O
 
0
 
U
O
6
!
l
U
V
 
O
Q
O
'
O
L
 
O
0
0
'
t
 
O
O
t
 
O
t
 
t
 
L
'
O
 
t
O
'
O
 
L
O
0
'
O
 
L
O
0
0
"
O
 
O
0
0
'
O
t
 
O
0
0
'
t
 
0
0
1
.
 
O
~
 
g
 
t
'
O
 
L
O
'
O
 
L
O
0
"
O
 
t
O
0
0
"
O
 
.
.
.
.
.
.
.
 
L
 
.
.
.
.
.
.
.
 
L
 
.
.
.
.
.
.
.
 
L
 
.
.
.
.
.
.
.
 
L
 
.
.
.
.
.
.
 
L
 
.
.
.
.
.
.
.
 
I
,
,
 
.
.
.
.
.
.
 
L
 
.
.
.
.
.
.
.
 
I
.
 
.
.
.
.
.
.
 
.
 
O
t
,
O
.
 
t
 
.
.
.
.
.
.
.
 
t
 
.
.
.
.
.
.
.
 
L
 
.
.
.
.
.
.
 
t
 
.
.
.
.
.
.
.
 
L
 
.
.
.
.
.
.
 
L
 
.
.
.
.
.
.
.
 
L
 
.
.
.
.
.
.
.
 
L
 
.
.
.
.
.
.
.
 
L
 
.
.
.
.
.
.
.
 
0
[
'
0
"
 
/
 
(
~
E
:
6
S
)
~
:
:
I
~
 
"
 
o
o
'
o
 
-
 
=
 
i
 
.
.
.
.
.
 
=
 
.
.
.
.
.
 
=
 
o
o
-
o
 
,
/
,
/
 
-
 
[
 
/
/
i
 
,
'
 
-
 
o
~
.
o
 
(
v
e
e
)
~
.
~
 
i
"
 
.
e
 
/
 
/
 
/
 
-
 
0
t
,
'
0
 
-
 
O
g
'
O
 
-
 
0
9
"
0
 
0
t
,
'
0
 
q
 
O
g
'
O
 
O
~
 
O
e
'
O
 
"
0
 
,
-
o
 
,
o
-
o
 
'
 
i
t
 
'
,
=
0
 
O
0
0
'
O
L
 
(
)
0
0
'
 
t
 
0
0
t
 
O
L
 
t
 
.
.
.
.
.
.
.
 
L
 
.
.
.
.
.
.
.
 
,
 
L
 
.
.
.
.
.
.
.
 
L
,
 
.
.
.
.
.
.
 
L
~
 
.
.
.
.
 
L
 
.
.
.
.
.
.
.
 
(
v
t
c
~
 
_
.
 
j
j
A
m
~
 
/
 
.
e
 
o
,
;
 
.
.
o
~
r
 
"
~
 
~
p
o
*
~
 
t
'
O
 
L
O
'
O
 
t
O
0
"
O
 
t
O
O
0
"
O
 
I
.
 
.
.
.
.
.
.
 
L
 
.
.
.
.
.
.
 
,
.
 
i
.
 
.
.
.
.
.
.
 
-
-
-
~
 
-
 
o
o
'
o
 
.
o
 
,
,
"
 
-
 
O
V
O
 
,
,
 
/
 
,
,
 
-
 
0
,
3
"
0
 
-
 
O
e
'
O
 
-
 
O
t
,
'
O
 
p
t
 
S
~
 
.
.
.
4
)
'
"
 
O
0
0
"
O
L
 
o
o
o
'
t
 
G
O
t
 
O
t
 
t
 
.
.
.
.
 
,
,
 
,
 
L
 
.
.
.
.
.
.
.
 
L
 
.
.
.
.
.
.
.
 
I
.
 
.
.
.
.
.
.
 
L
 
.
.
.
.
.
 
L
 
.
.
.
.
.
.
.
 
L
.
 
.
.
.
.
.
.
 
L
 
.
.
.
.
.
.
.
 
L
,
,
,
,
,
 
,
 
6
 
.
.
.
.
.
 
￿
9
 
.
.
.
.
.
.
 
e
'
"
 
o
v
o
 
:
3
 
3
 
~
o
 
8
 
O
O
t
 
.
.
.
.
 
,
,
,
 
,
 
I
 
.
.
.
.
.
.
 
,
 
,
 
i
 
!
'
-
-
-
"
 
-
-
 
(
i
w
/
S
n
)
 
u
o
.
q
~
u
o
o
u
o
o
 
u
 
.
e
~
u
v
 
O
|
 
t
 
I
.
'
0
 
L
O
'
O
 
L
O
0
"
O
 
L
O
G
O
'
O
 
O
t
 
,
'
/
 
,
/
/
"
 
~
"
 
.
'
"
 
o
[
~
 
.
"
 
o
O
"
 
.
"
 
/
 
I
 
g
i
;
i
 
a
 
g
:
 
L
 
~
N
~
a
 
l
,
:
 
L
 
.
L
M
~
(
]
 
-
 
0
0
"
0
 
-
 
O
V
O
 
-
 
(
l
E
O
 
-
 
o
s
 
-
 
O
l
Y
O
 
.
.
.
.
 
.
.
.
.
.
.
.
.
 
%
.
"
 
.
o
 
~
"
 
.
.
.
.
 
.
.
.
E
~
 
.
.
.
.
.
.
.
.
 
E
~
 
.
.
.
.
'
"
 
1
~
:
:
:
:
-
-
-
-
0
 
.
.
.
.
.
.
.
.
 
~
"
 
I
 
.
.
.
.
.
"
 
g
 
i
i
 
a
 
~
~
 
.
.
.
.
 
s
 
.
.
.
.
 
8
:
 
L
 
~
0
 
o
 
.
.
.
.
.
.
.
.
 
~
"
 
!
~
:
 
L
 
.
I
.
N
~
C
]
 
(
l
u
~
e
m
e
d
n
s
 
%
)
 
u
o
.
q
e
q
u
e
o
u
o
o
 
X
p
o
q
.
q
w
 
L
 
,
.
o
 
~
o
-
o
 
=
o
o
.
o
 
=
o
o
o
.
o
 
,
~
o
o
.
o
 
=
o
o
~
o
 
I
 
.
.
.
.
.
.
.
.
 
I
 
.
.
.
.
.
.
.
.
 
I
 
.
.
.
.
.
.
.
.
 
h
 
.
.
.
.
.
.
.
 
I
 
.
.
.
.
.
.
.
.
 
L
*
 
.
.
.
.
 
,
 
,
 
,
r
-
-
 
I
1
0
"
0
 
~
 
g
,
 
o
 
g
 
o
v
o
 
o
 
.
.
~
 
"
a
 
V
 
0
1
,
'
0
 antigen response (bottom left) when relative responses to anti- 
CD3 mAb were taken into account. The amino acid substi- 
tution D5c~(Y31A) caused an "~l,000-fold  shift in the an- 
tigen dose-response curve (top right); when relative responses 
to anti-CD3 mAb are taken into account, this dose shift trans- 
lates to a 6,000-fold decrease in antigen recognition. Finally, 
the substitution DSc~(S93A) eliminated the response to an- 
tigen (bottom right); when relative  responses to anti-CD3 mAb 
are taken into account,  this dose shift translates to at least 
a 50,000-fold decrease  in antigen recognition. In this manner, 
we calculated relative antigen recognition from multiple ex- 
periments for each of the transfectants and displayed them 
in Fig. 5. 
Residues that appear critical for the recognition of an- 
tigen/MHC in the D5 TCR are those residues that decrease 
antigen recognition at least 10-fold when substituted with 
Ala (or Gly or Ser in the case of Tyr-26); Tyr-24, Tyr-26, 
Tyr-31, Lys-48, Tyr-50, Ser-93, Asn-94, and Ile-98. We are 
less certain about the absolute role of Tyr-49; its substitution 
with Ala decreased antigen recognition ,vl0-fold, but the 
decrease ranged between twofold and 50-fold in five  experi- 
ments (Fig. 5). Amino acid substitutions  K48A, $93A, and 
N94A completely eliminated antigen responses, while sub- 
stitutions Y24A, Y31A, and Y50A severely affected antigen 
responses (displaying a slight antigen response at the highest 
antigen concentration tested). These cell lines expressed sur- 
face CD4, CD45, and LFA-1 at levels comparable with that 
expressed by DScxWT cells, as determined by flow cytom- 
etry (data not shown), demonstrating that the loss of these 
molecules did not account for the observed decreases in an- 
tigen recognition. Amino acid substitutions  Y26S, Y26G, 
and I98A moderately decreased  antigen responses. Amino add 
substitutions $25A, Y26F, $27A, T29A, S5LA, D53A, N95A, 
N96A, and R97A had little or no effect on antigen recogni- 
tion. None of the amino acid substitutions  substantially in- 
creased  relative antigen recognition. In sum, these results dem- 
onstrate that residues in all three antigen binding loops are 
Figure 6.  Surface  expression of TCR. a/•  chains by transfectants ex- 
hibiting severely diminished responses to antigen. Cell surface proteins 
of transfectants D5cxWT, Y24A, Y31A, K48A, Y50A, $93A, and N94A 
were labeled with 12Sl using lactoperoxidase, solubilized in 1% digitonin, 
immunoprecipitated  with 2Cll anti-CD3 mAb, and analyzed by two- 
dimensional  NEPHGE  and SDS-PAGE. The  entire gd  derived  from 
D5~WT, but only the relevant portions of the autoradiograms from trans- 
fectants expressing variant TCR or/13 chains (•30-50  kD), are shown. 
Because of differences  in the numbers of ceils labded and in exposure time 
of autorediograms, these results do not indicate absolute amounts of TCR 
c~ or ~ chains e~pressed on a given cell line. TCR oz/15 chains are indi- 
cated; molecular mass markers are shown on the left (in kD). 
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Figure 5.  Rehtive responses to Ars-OVA/I-Aa by 
cells expressing the variant forms of the D5 TCR c~ 
chain. IL,2 secretion by cell expressing DSaWT or 
variant D5 TCIL was measured in response to several 
doses of Ars-OVA or 2Cll anti-CD3 mAb cuhured 
with TA3 cdls, as in Fig. 4. Ikehtive antigen  recogni- 
tion by transfectants was calculated as described in 
Materials and Methods, tolring  into account responses 
to anti-CD3 mAb, relating antigen recognition to 
transfectants exp~ssing wild-type D5 TCR (WT - 
1.0). Each point represents an independent e~riment 
with the same transfectant done or the same experi- 
ment with different clones. Bars indicate geometric 
mean (, t/IX1XzX3... X,I) of three to six experi- 
ments, except for D5a(Y26S), which was tested in 
a single e~n'irnent.  Experiments in which no antigen 
response was detected at the highest antigen concen- 
tration tested are indicated with a triangle; such e~- 
periments  potenthlly  overestimate  relative  antigen  rec- 
ognition,  thus  undemtimating  the effect  of  a particular 
amino acid substitution. 
1558  The Antigen Binding Site on the T  Cell Receptor  <x Chain important in recognition of antigen/MHC and that significant 
structural alterations in side chains can be tolerated at certain 
positions in each loop. 
Surface Expression of TCR ot/~ Chains in Transfectants Dis. 
playing Severely Diminished or Eliminated Antigen Responses. 
We examined whether transfectants displaying little or no 
response to antigen expressed surface TCK c~/~ chains. Sur- 
face proteins of wild-type transfectant and selected transfec- 
tants (Y24A, Y31A, K48A, Y50A, $93A, N94A) were la- 
beled with tzsI by lactoperoxidase, lysed with 1% digitonin 
and immunoprecipitated with  2Cll  anti-CD3  mAb.  Im- 
munoprecipitates were subjected to NEPHGE and SDS-PAGE 
to separate TCK ot and/3 chains, as shown in Fig. 6.  All 
cell lines expressed both ot and/~ TCR chains in TCR/CD3 
complexes, indicating that their decreased antigen responses 
were not due to improper chain association or the expression 
of nonclassical TCR (such as ~-B or B-/~ dimers). The rela- 
tive decrease in the labeling of the c~ chain in the transfec- 
tants expressing the Y31A or Y50A variants suggests that 
Tyr-31 and Tyr-50 are targets for iodination in the c~ chain. 
The same panel of transfectants stained as well as the wild- 
type transfectant with B20.6 anti-murine V/$2 mAb, demon- 
strating that the amino acid substitutions in the c~ chain did 
not affect the epitope on VB2 recognized by this mAb (data 
not shown). 
The Effect of Araino Acid Substitutions Introduced into the D5 
TCR cr Chain on Specificity  for Hapten or Carrier Antigen.  We 
tested whether amino acid substitutions introduced into the 
D5 TCR ot chain affected the pattern of reactivity towards 
various arsonate~conjugated antigens presented by cells bearing 
I-A  a,  as displayed in Fig.  2.  For most of the transfectants 
bearing variant D5 TCR (and showing II-2 responses strong 
enough to be recorded), this pattern of relative potency was 
not affected: the degree of shift in the dose-response curves 
to the other arsonate-conjugated antigens was roughly equal 
to that observed for Ars-OVA (data not shown). However, 
cells expressing the TCR variant DSoe(I98A) displayed a pat- 
tern of reactivity towards the various arsonate-conjugated an- 
tigens that was qualitatively different from that displayed by 
cells expressing the wild-type D5 TCR (Fig. 7; for simplicity, 
only the responses to the antigens Ars-OVA, Ars-tOVA, and 
Ars-BGG are shown). Although the dose responses of cells 
expressing DSoe(I98A) to Ars-OVA and Ars-tOVA (Fig.  7), 
as well as Ars-KLH and Ars-HEL (data not shown), were 
equivalently shifted to  100-1,000-fold higher antigen con- 
centrations, the response to Ars-BGG was decreased only 10- 
fold. Identical results were obtained in three independent ex- 
periments testing the response of cells expressing D5ce(I98A) 
to this panel of antigens (data not shown). Thus, the substi- 
tution I98A had the net effect of creating a TCR that now 
recognized Ars-BGG better than it recognized Ars-tOVA. 
We tested whether cells expressing variant D5 TCR ex- 
hibited a different pattern of reactivity towards OVA con- 
jugated with arsonate or its structural analogues benzoate 
and sulfonate. For all of the transfectants that exhibited a re- 
sponse to these antigens strong enough to be detected, there 
was no difference in the pattern of relative potency of hapten- 
OVA conjugates (data not shown). 
1559  Nalefski  et al. 
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Figure 7.  Responses  to various arsonate-conjugated  antigens/l-A  d by 
cells expressing the wild-type  or variant 198A of the D5 TCR o~ chain. 
I1:2 secretion  by cells expressing  D5o~WT (top) or D5r,(198A) (bottom) 
was measured  in response  to the indicated  amounts  of arsonate-conjugated 
antigens  cultured  with TA3 cells. The responses  to An-OVA (fiUedcircles). 
Ars-tOVA (filled  squares), and Ars-BGG (filled triangles)  were tested  using 
dilutions of supernatants from cells for which I1:2 secretion  in response 
to anti-CD3 mAb was matched  as in Fig. 4 A. I1:2 secretion  was deter- 
mined  as in Fig. 2. Identical  results  were  obtained  in two other  experiments. 
Discussion 
Similarity between the TCK and Ig exists at several levels. 
Both are encoded by rearranged gene segments organized in 
a similar manner (reviewed in reference 2). A great deal of 
similarity exists at the level of primary sequence, especially 
in residues thought to be important in maintaining their struc- 
ture (2-5). On the basis of these similarities, we have altered 
residues predicted to form the antigen binding loops of a model 
TCR that recognizes arsonate-conjugated  antigens. Fig. 8 sum- 
marizes our results, which demonstrate that all three predicted 
antigen binding loops of the D5 TCR oe chain are likely to 
play an important role in the recognition of antigen/MHC. 
The Effect of Ala Substitutions on Overall TCR  Confirma- 
tion.  The amino acid substitutions we have introduced into 
the D5 TCR cr chain are unlikely to disrupt the overall con- 
formation of the TCR. As outlined in Fig.  1, we modeled 
the TCR. primary structure upon that of an Ig domain ac- 
cording to Chothia et al. (5) and then intentionally directed 
our amino acid substitutions to residues forming the predicted al 
E 
Figure 8.  Summary  of  the effects  of amino acid  substitutions  introduced 
into the predicted  D5 TCR antigen binding loops. Shown  is a schematic 
representation  of the antigen/MHC binding site on the D5 TCR based 
on the model  proposed  by Chothia et al. (5) and outlined  in Fig. 1, high- 
lighting the effect  of amino  acid substitutions  introduced  into the D5 TCR 
chain on Ars-OVA/I-A  d recognition. Bold symbols around residues 
(using a single-letter  code for amino adds) denote those that were tested 
in the present study, the results of which are shown in Fig. 5. Squares 
denote residues that, when substituted with Ala (or Gly or Set in the 
case of Tyr-26), cause  a >10-fold decrease  in response of the D5 TCR to 
An-OVA presented  by cells  bearing  I-A  d. Continuous symbols  denote  the 
residues  in antigen  binding  loops o~1-a3  and ~1-B3; a dotted  symbol  denotes 
Tyr-24, the last residue  of the B ~ strand  in the TCR c~ chain. The substb 
tution of Ala for Ile-98, located  in the antigen binding loop c~3 predicted 
to contact  antigenic  peptides, caused  a change  in carrier  peptide specificity 
in the D5 TCR. Note that this figure indicates the relative position of 
the antigen  binding loops and the residues  that form  them, not necessarily 
the conformation  of the loops. 
antigen binding loop regions of the TCK c~ chain. As Ala 
is one of the most abundant amino acids and is found both 
buried or exposed to solvent in protein structures (26),  sub- 
stitution with it should be tolerated in a loop structure. In 
fact,  surface staining  with  an  anti-V/32  antibody (B20.6) 
demonstrated that the variant TCK exhibiting decreased an- 
tigen recognition retained the epitope recognized by this mAb 
(data not shown). The only substitution that might possibly 
influence the conformation of the o~ chain is Y24A. Because 
93% of the TCK ot chains analyzed bear His, Tyr, or Phe 
at position 24 (5), the substitution Y24A could disrupt the 
local conformation of the B/3 strand, rather than affecting 
contact with antigen. 
The importance of/3 strand residues in determining the 
overall conformation of the Ig fold has been demonstrated 
in a similar study involving CD4. Ala was systematically sub- 
stituted for each of 64 hydrophilic and hydrophobic residues 
in the NH2-terminal domain of the Ig-like molecule CD4 
to determine residues important in the interaction with HIV 
gp120 (20). 14 Ala substitutions disrupted the conformation 
of CD4 as judged by antibody binding: 10 of these residues 
are found in/3 sheets, while only one of the remaining four 
is in a position analogous to the Ig antigen binding loops 
between/3 strands (27,  28), 
The Effect of Ala Substitutions on Association of TCR ot and 
Chains.  The model proposed by Chothia et at. (5) predicts 
that  the TCR  residues  that  probably  have  the  strongest 
influence on chain pairing are those residues in the C, C', 
F, and G/3 strands that are involved in the TCR ~/3 inter- 
face, and we carefuUy avoided making substitutions at these 
residues.  In fact, each variant TCR generated was efficiently 
expressed on the surface of 11hc~- cells (as judged by flow 
cytometry using anti-CD3e and anti-V/32 mAb and immu- 
noprecipitation of surface iodinated proteins) and could be 
stimulated with anti-CD3e mAb, demonstrating that the sub- 
stitutions disrupted neither association with the normal D5 
TCR/3 chain or CD3 polypeptides, nor signaling through 
invariant portions of CD3. 
There is a strict requirement for the presence of both oL 
and/3 TCIL chains for successful  surface expression of the 
TCR/CD3 complex in 11hol- cells, which have deleted the 
Vo~ gene segment rearranged and expressed on D5 cells. This 
strict requirement is born out by the fact that we observe 
regained surface CD3 expression in the 11hc~- recipient only 
upon transfection with  DNA  encoding the wild-type or 
variant  D5  TCR  ol  chain.  Mock-transfected cultures  of 
11ho~- cells have never been observed to show any trace of 
surface TCR/CD3 expression as analyzed by flow cytometry. 
Indeed, continuous cnlturing of the 11oL- T cell done and 
the 11hc~- T  cell hybridoma has never led to the develop- 
ment of any cells expressing detectable surface CD3. Moreover, 
we have shown directly by surface iodination and immuno- 
precipitation that surface TCR c~ and/3 chains are expressed 
in transfectants exhibiting low or no response to antigen, 
ruling out the possibility that solely/3-/3 homodimers or non- 
dassical TCR heterodimers (such as/3-/~) (29)  appeared in 
our transfectants that exhibited low or no response to an- 
tigen (Fig. 6). Our observations are in complete agreement 
with those reported by Saito  et al.  (30),  in which TCR/3 
chain dimers were not detected in T  ceU mutants deficient 
in c~ chain expression. 
Validity of the lg Model of the TCR.  Our results demon- 
strate  that  residues  important  in  the  recognition  of an- 
tigen/MHC by the D5 TCR include: Tyr-24, Tyr-26, Tyr- 
31, Lys-48, Tyr-50, Set-93, Asn-94, Ile-98, and possibly Tyr-49 
(Figs.  5 and 8).  We propose that these residues, located in 
or immediately adjacent to proposed antigen binding loops, 
either determine the conformation of the antigen binding 
loops on the D5 TCR or directly contact some portion of 
the antigenic peptide/MHC ligand. Our results are consis- 
tent with the Ig modal for the TCR and imply that prin- 
ciples similar to those that are involved in antibody interac- 
tions with globular antigens might govern TCR recognition 
of its ligand. For example, the specificity of the TCR for 
antigen/MHC probably arises from the complementarity of 
TCR and antigen/MHC surfaces that span the same approx- 
imate area as those involved in antibody-antigen complexes. 
Because the TCR simultaneously contacts multiple residues 
on both ol helices of the MHC molecule, it has been previ- 
ously estimated that the interface between the TCR and an- 
tigen peptides/MHC molecule spans 600-780 A  2 of surface 
1560  The Antigen Binding Site on the T Cell Receptor ot Chain area (31); this estimate agrees well with the 600-900 A2 of 
surface area involved in the structures  of antibody-antigen 
complexes determined to date (23). Our results indicate that 
seven to nine residues of the TCR c~ chain are potentially 
in simultaneous contact with antigen/MHC. This number 
agrees well with the 7-11 light chain residues that make con- 
tact with protein antigens in the four Fab structures that have 
been determined (23), suggesting that TCR ot chain contact 
with antigen/MHC also involves some 300-400 A2 of sur- 
face area. Furthermore, it has been suggested that aromatic 
interactions  play an important role in antigen recognition 
because of the high degree of solvent accessibility of aromatic 
residues in antibody combining sites (32). In the case of the 
D5 TCR, multiple Tyr residues are important in antigen/ 
MHC reactivity (Figs. 5 and 8); Tyr may play a particularly 
important role in antigen/MHC recognition by the D5 TCR 
because of the nature of its ligand (see below). 
TCR Residues That Contact Antigenic Peptides or the MHC 
Molecule.  The current model of the  TCR  predicts  that 
residues in the third antigen binding loop contact mainly an- 
tigenic peptides (5-7). Consistent with this modal, the amino 
acid substitution D5c~(I98A) selectively alters the pattern of 
recognition of a subset of the arsonate-conjugated  antigens 
that were tested,  suggesting that the amino acid Ile-98 in 
antigen binding loop cr  contacts the antigenic carrier pep- 
tide to which an arsonate hapten has been attached (Fig. 7). 
Our results are consistent with other instances in which par- 
ticular amino acids in the third antigen binding loop of TCR 
chains have been implicated in contact with antigenic pep- 
tides. Amino acid residues at position 100 of antigen binding 
loop B3 in pigeon cytochrome c-specific  TCR have  been shown 
to affect the fine spedficity of those TCR for antigen (33, 
34). More recently, direct contacts between the TCR c~ chain 
residue 93 in c~3 and B chain residue 100 in/33 and cytochrome 
c peptides bound to I-E  k have been proposed  (35). 
The substitution of Ala for Ile-98 results in the removal 
of its B-methyl and B-ethyl groups, making the side chain 
considerably smaller. If Ile-98 contacts an antigenic peptide, 
substitution of bulkier side chains for residues on the anti- 
genic peptide might compensate for the substitution of Ala 
for I1e-98. We are currently testing this  hypothesis  with 
arsonate-conjugated  peptide Ova(36-50). 
In keeping with the current model for the TCR, Ser-93 
and Asn-94, also in antigen binding loop or3, are predicted 
to contact some portion of the hapten-conjugated antigen 
recognized by the D5 TCR. Because the substitution of both 
these residues eliminated responses to all antigens tested, we 
could not establish whether they contact the hapten itself 
or some portion of the peptide.  Nevertheless, the elimina- 
tion of an antigen response by the removal of a single hydroxyl 
group in the substitution D5c~(S93A) illustrates the remark- 
able influence that small structural changes can have on T 
cell recognition. 
The current model for the TCR also predicts that residues 
in eel and o~2 primarily contact the ce helices of the MHC 
molecule. In keeping with this model, Tyr-26, Tyr-31, Lys- 
48, Tyr-50, and possibly Tyr-24 are predicted to interact with 
residues on the I-A  d molecule. It is noteworthy that each of 
the 17 human or murine TCR V~x sequences in subgroup 
4 analyzed  by Chothia et al. (5), to which Vc~3  family members 
belong, possesses either Arg or Lys at position 48, the first 
position of antigen binding loop c~2. Since these TCR recog- 
nize various antigen/MHC combinations,  it is tempting to 
speculate that the positively charged residue at position 48c~ 
in all of the TCR in this subgroup might interact  with a 
conserved negatively charged residue on an ot helix of the 
MHC molecule. 
Comparison between Antiarsonate Ig and TCR.  Recently 
the high-resolution three-dimensional  structures of two an- 
tiarsonate antibodies have been determined by x-ray diffrac- 
tion (36, 37). In one of the structures,  an arsonate binding 
site was modeled at the bottom of a conical "pit" formed 
by antigen binding loops L3, H2, and H3 (37, 38). The pres- 
ence of this hapten binding site was supported by several lines 
of experimental evidence: conservation of residues throughout 
high affinity antiarsonate antibodies, site-directed mutagen- 
esis, and comparison of three-dimensional  structures of two 
antiarsonate antibodies. The hapten binding site was formed 
by the light chain residue Arg-96, heavy chain residues Asn- 
35, Ser-99, and Trp-47, and a tightly bound water molecule 
that hydrogen bonded to the arsonate moiety; heavy chain 
residues Tyr-50 and Tyr-106 packed against the phenyl rings 
of the hapten. Substitution of Ala for each of these residues 
severely diminishes the binding of the antibodies to the ar- 
sonate hapten (37, 39; and S. Sompuram andJ. Sharon, per- 
sonal communication). 
We were surprised to observe that analogous amino acid 
substitutions introduced into the D5 TCR c~ chain severely 
impaired the ability of the D5 TCR to recognize arsonate- 
conjugated antigens presented by I-Aa: substitution of Ala 
for Tyr-31 and Tyr-50 in the proposed antigen binding loops 
and Tyr-24 in an adjacent B strand; substitution of Ala for 
Set-93; substitution of Ala for Ash-94; substitution of Ala 
for Lys-48. Even though the contribution orb chain residues 
has not been taken into account, this coincidence could imply 
that similar molecular interactions  occur between arsonate 
and an antiarsonate antibody and the arsonate hapten con- 
jugated to an antigenic carrier peptide and the D5 TCR. By 
analogy to antiarsonate  antibodies,  one model that can be 
proposed is that D5 TCR ot chain residues Tyr-31 or Tyr-50 
(or Tyr-24) pack against  the phenyl rings of the arsonate 
hapten, and Lys-48, Set-93, and Asn-94 hydrogen bond to 
the arsonate moiety of the hapten.  A great deal of binding 
energy might be created through the packing of aromatic 
rings of TCR residues and the phenyl ring of the arsonate 
moiety, as has been calculated for other aromatic-aromatic 
interactions in protein structures  (40). Because their substi- 
tutions are more easily tolerated, Tyr-26 in antigen binding 
loop or1 and possibly Tyr-49 in c~2 probably contact some 
portion of the I-A  d molecule. 
If this modal for TCR residues that contact the arsonate 
hapten is correct, it would contradict the current model of 
the TCR that residues in the first and second antigen binding 
loops contact mainly residues of the MHC molecule (5-7). 
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ment except for Ash-94 and all critical for the specificity of 
the D5 TCR, might explain the observed correlation between 
usage of the Vol3 gene segment and reactivity to arsonate (10). 
It is possible that hapten-specific TCR might not recog- 
nize antigenic peptides in exactly the same manner as other 
"conventional" TCR,  since the hapten moiety might  con- 
tribute a disproportionate amount of binding energy to the 
TCR/MHC/haptenated  peptide complex. In the case of Ig, 
x-ray crystallography has shown that  the binding of small 
molecules such as haptens to antibodies is similar but not 
identical to the binding  of larger  protein antigens to anti- 
bodies: small molecules bind in clefts between antigen binding 
loops on the ends of antibodies while globular proteins pack 
against these loops, forming relatively flat surfaces without 
extensive protusions (reviewed in reference 23). Nevertheless, 
the study of hapten-specific antibodies was critical for our 
understanding of antibody-antigen interactions. The results 
provided in this report, which are consistent with the Ig model 
of the TCR, demonstrate how the molecular interactions in- 
volved in the ternary complex of TCIL/antigenic  peptide/ 
MHC can be elucidated using a hapten-specific TCR. 
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